论文信息 - Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019 - 字舞流文

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

Ryan J. Anderson | R. Razonable | Ravindra Ganesh | B. Kennedy | Richard F. Arndt | D. Challener | S. Hall | Ryan J Anderson | J. O’Horo | Perry W. Sweeten | Sara Ausman | Alexander Heyliger | Sara E Ausman